Ethics statement
The studies involving human participants were reviewed and approved by the internal review boards for the parent clinical trial (NCT01150695). Subjects gave their consent for inclusion before they enrolled in the parent clinical trial (NCT01150695). The original protocol and consent form were reviewed by the US Food and Drug Administration, and approved and monitored by the sites’ institutional review boards. The patients/participants provided their written informed consent to participate in this study.